| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/27/2005 | CN1646123A Therapeutic agent for food competence disorder in stomach |
| 07/27/2005 | CN1646118A Pharmaceutical composition for preventing or treating respiratory disease |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/26/2005 | US6921835 Carbocyclic carboxy amines such as 1-aminomethyl-3,4-dimethyl-cyclopentyl acetic acid or prodrugs used as antiepileptics, antidepressants, anxiolytics, analgesics, antiinflammatory agents and for prophylaxis of neurodegenerative disorders |
| 07/26/2005 | US6921831 Contacting alkene or alkadiene with a catalyst consisting of bismuth, lead, molybdenum, oxygen, and at least one metal selected from the group consisting of copper, gold and vanadium in vapor-phase to form furan compound |
| 07/26/2005 | US6921830 Separation of low boiling and high boiling fractions from gas mixtures, then distilling and reusing |
| 07/26/2005 | US6921822 Reduction of the corresponding ketone compound using ruthenium catalyst |
| 07/26/2005 | US6921774 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders |
| 07/26/2005 | CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 07/26/2005 | CA2131571C Bisphosphines for asymmetric hydrogenation catalysts |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066151A2 Histone deacetylase inhibitors |
| 07/21/2005 | WO2005066149A1 Process for the preperation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof |
| 07/21/2005 | WO2005066116A1 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors |
| 07/21/2005 | WO2005065778A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005065050A2 Bicyclic compound |
| 07/21/2005 | WO2005043124A3 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 07/21/2005 | US20050159491 Cerebrovascular and cardiovascular diseases; hot water extracting danshen plant and chromatographic separation on polyamide column; high yield, low cost, quality |
| 07/21/2005 | US20050159487 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 07/21/2005 | US20050159481 4,6-di-t-butyl-5-hydroxy-2,2-di-n-pentyl-2,3-dihydrobenzofuran; side effect reduction: lowers high-density lipoprotein cholesterol (HDL-C), prolongs electrocardiographic QT intervals; myocardial infarction, hypotensive, antidiabetic, anticoagulant, arteriosclerosis obliterans, intermittent claudication |
| 07/21/2005 | US20050159476 Pharmaceutical composition for preventing or treating respiratory disease |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159402 Polyarylcarboxamides useful as lipid lowering agents |
| 07/21/2005 | US20050159314 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent |
| 07/21/2005 | US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2552713A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2552090A1 Disubstituted chalcone oximes as selective agonists of rar.gamma. retinoid receptors |
| 07/20/2005 | EP1554262A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1483252B1 Method for purifying tetrahydrofuran by distillation |
| 07/20/2005 | EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 07/20/2005 | EP1305305A4 Hyperpolarizable organic chromophores |
| 07/20/2005 | EP1290000A4 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1242354B1 Method and device for cooling a hot reactor gas, for example in the production of phthalic anhydride |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1183101B1 Vanadium/phosphorus mixed oxide precursor and catalyst and their preparation |
| 07/20/2005 | EP1108706B1 Catalytic synthesis of aldehydes by direct hydrogenation of carboxylic acids |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642933A Cyclic hemiacetal derivative and use thereof |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642641A Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof |
| 07/20/2005 | CN1642640A Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1211377C Preparation of citalopram |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211361C Fused-ring carboxylic acid derivatives |
| 07/20/2005 | CN1211082C Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 07/19/2005 | US6919475 A chemical intermediate for use in positron emission tomography, radioactive fluoride compounds with long half life |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919329 Microorganisms; bactericides; human and veterinary medicine |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063727A1 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/14/2005 | WO2005063726A1 Novel alkoxylactones, alkoxylactames and alkoxythiolactames for controlling processes based on microbial interaction |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063692A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 07/14/2005 | WO2005063689A1 Benzamide derivative |
| 07/14/2005 | WO2005063233A1 Composition for preventing and treating hepatoma |
| 07/14/2005 | WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR |
| 07/14/2005 | WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/14/2005 | WO2005021527A3 Process for the asymmetric hydrogenation of beta-amino ketones |
| 07/14/2005 | US20050154230 Urea derivatives |
| 07/14/2005 | US20050154216 Stereospecific synthesis of 3-[(3,5-dihalo-4-(2-(diethylamino)ethoxy)benzoyl]-2-alkoxycarbonylbenzofurans; carbonylation of methyl benzofuran-2-acetate with p-methoxybenzoyl chloride, hydrolysis, halogenation, esterification with an alkanol, and etherification with 2-chlorotriethylamine; pharmacokinetics |
| 07/14/2005 | US20050154214 Formed by heating vanadium pentoxide suspended in liquid with solution of silver salt, and isolating the product; spray drying; filtering; drying; for production of catalysts for gas-phase partial oxidation of aromatic hydrocarbons |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154062 Substituted chiral allosteric hemoglobin modifiers |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050154053 Methods and compositions for immunomodulation |
| 07/14/2005 | US20050154052 Novel crystalline forms of (s)-citalopram oxalate |
| 07/14/2005 | US20050154051 Method for the preparation of escitalopram |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153870 Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome |
| 07/14/2005 | US20050153834 for heterogeneously catalyzed gas-phase oxidation of butane to maleic anhydride; calcining vanadium, phosphorus and oxygen containing precursor particles having an averaged diameter of at least 2 mm moving at a steady speed; controlled variation over time of gas temperature in relation to set point value |
| 07/14/2005 | US20050150764 3-Phenyl-4-(pyrazol-1-yl)-1-(4-substituted-phenylamino)carbonyl-1,4,5,6-tetrahydropyridazines; insecticides, arachnidicides, nematocides; plant protection agents; [specifications are a pesticide, but claims are the quantitative voltammetric determination of an ion in a fluid using a coated electrode] |
| 07/14/2005 | DE10357717A1 Katalysatorextrudate auf Basis Kupferoxid und ihre Verwendung zur Hydrierung von Carbonylverbindungen Catalyst extrudates based on copper oxide and their use for the hydrogenation of carbonyl compounds |
| 07/14/2005 | DE10357716A1 Verbesserter Katalysator für die Hydrierung von Maleinsäureanhydrid zu γ-Butyrolacton und Tetrahydrofuran Improved catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran and γ-butyrolactone |
| 07/14/2005 | DE10357715A1 Verfahren zur Herstellung von definierten Gemischen aus THF, BDO und GBL durch Gasphasenhydierung Process for the preparation of defined mixtures of THF, GBL and BDO by Gasphasenhydierung |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2549506A1 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551821A1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 07/13/2005 | EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | EP1551392A2 Novel lapacho compounds and methods of use thereof |
| 07/13/2005 | EP1551384A2 R-nsaid esters and their use |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | CN1639146A Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 07/13/2005 | CN1639145A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |